Biotech PolyNovo crashed into the ASX200 last month, after a spectacular turnaround engineered by chairman David Williams (of Kidder Williams fame) and his CEO Paul Brennan.
Paul Brennan doesn't sit on PolyNovo's board, so he doesn't have to file 3Y notices. Eamon Gallagher
Loading...
Myriam Robin is a senior writer based in the Melbourne newsroom. She has previously been a Rear Window columnist and editor, and before that reported on financial markets and media. Connect with Myriam on Twitter. Email Myriam at myriam.robin@afr.com
